Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Crossref DOI link: https://doi.org/10.1007/s10198-017-0942-2
Published Online: 2017-11-27
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jacobs, Maartje S. http://orcid.org/0000-0002-6185-4718
de Jong, Lisa A.
Postma, Maarten J.
Tieleman, Robert G.
van Hulst, Marinus
License valid from 2017-11-27